Zobrazeno 1 - 10
of 1 237
pro vyhledávání: '"Drug Survival"'
Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study
Autor:
Tiago Torres, Maria João Cruz, Margarida Gonçalo, Paulo Filipe, Bruno Duarte, João Alves, José Miguel Alvarenga, Gilberto Rosa, Duarte Flor, José Ramos, Diogo Sousa, Aureliu Rosca, César Magalhães, Cristina Claro, Joana Rocha, Catarina Vilarinho, Fernando Mota, Alberto Mota, Maria João Paiva Lopes
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 8, Pp 2209-2221 (2024)
Abstract Introduction Several clinical trials have established the efficacy and safety of dupilumab for treating atopic dermatitis (AD). However, literature remains scarce in reporting the long-term effectiveness, safety, and drug survival of dupilum
Externí odkaz:
https://doaj.org/article/6c3eb3f5268e43d09777d0ea3da93227
Autor:
Bucur S, Serban ED, Ileanu BV, Costache RS, Nicolescu AC, Constantin T, Costache DO, Constantin MM
Publikováno v:
Psoriasis: Targets and Therapy, Vol Volume 14, Pp 79-86 (2024)
Stefana Bucur,1,2 Elena-Daniela Serban,1 Bogdan Vasile Ileanu,3 Raluca Simona Costache,4,5 Alin Codrut Nicolescu,6 Traian Constantin,7,8 Daniel Octavian Costache,1,9 Maria-Magdalena Constantin1,2 1 2nd Department of Dermatology, “Carol Davila” Un
Externí odkaz:
https://doaj.org/article/15ed3da1699d4e038bd4453aa26fa752
Autor:
Oh Chan Kwon, Wonho Choi, Soo Min Ahn, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Min-Chan Park, Yong-Gil Kim
Publikováno v:
Advances in Rheumatology, Vol 64, Iss 1, Pp 1-7 (2024)
Abstract Background To assess the drug survival and change of disease activity using a second Janus kinase inhibitor (JAKi) after failure to a JAKi and subsequent biologic disease-modifying anti-rheumatic drugs (bDMARDs) in patients with difficult-to
Externí odkaz:
https://doaj.org/article/1d89bb57492641979a2490dcae8c0761
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
Autor:
Francesca Barei, Paolo Calzari, Luca Valtellini, Alessandra Chiei Gallo, Gabriele Perego, Simona Tavecchio, Martina Zussino, Angelo V. Marzano, Silvia Ferrucci
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Background Atopic dermatitis (AD) profoundly impacts patients’ lives, necessitating long-term systemic treatments.Methods This retrospective study involved 709 severe AD patients receiving dupilumab. Drug survival (DS) was analyzed using Kaplan-Mei
Externí odkaz:
https://doaj.org/article/c3cedb4b4eb94bc39837702e58b0f53f
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Biologics for psoriasis are efficient and safe, but very expensive. We investigated the association of the reducing copayment program (RCP) with changes in biologics use patterns depending on the income levels of patients with moderate-to-se
Externí odkaz:
https://doaj.org/article/d6834e77579f4d139a4e0a1377b0e9f1
Autor:
Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 3561-3574 (2023)
Filomena Russo,1 Marco Galluzzo,2,3 Luca Stingeni,4 Severino Persechino,5 Leonardo Zichichi,6 Andrea Conti,7 Claudia Giofrè,8 Valentina Dini,9 Martina Vispi,10 Laura Atzori,11 Angelo Cattaneo,12 Aurora Parodi,13 Federico Bardazzi,14 Giuseppe Stinco,
Externí odkaz:
https://doaj.org/article/115768c008944ac5b86654ed48f517a0
Autor:
Giacomo Caldarola, Marco Galluzzo, Nicoletta Bernardini, Elisabetta Botti, Eleonora De Luca, Clara De Simone, Marco Mariani, Gaia Moretta, Sabatino Pallotta, Elena Campione, Ketty Peris
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 2 (2024)
Introduction: Data about the long-term effectiveness of brodalumab could be valuable in assessing patient adherence to treatment and improving psoriasis management. Objective: The aim of our study was to evaluate the drug survival of brodalumab and
Externí odkaz:
https://doaj.org/article/c12852da8d7849db875d715e15d620bf
Autor:
Niccolò Gori, Alvise Sernicola, Ersilia Tolino, Maria Mariano, Marco Galluzzo, Gaia Moretta, Rosa Coppola, Andrea D’Alessio, Massimo Sansone, Virginia Maffei, Claudia Paolino, Cristian Ferrao, Lauro Cascia, Paola Addio, Lucia Di Nardo, Andrea Chiricozzi, Ester Del Duca, Antonio Cristaudo, Luca Bianchi, Sabatino Pallotta, Vincenzo Panasiti, Giovanni Pellacani, Concetta Potenza, Ketty Peris
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Objectives The purpose of this study was to analyze the drug survival rate of dupilumab up to 2 years in a large real-world cohort of adult patients affected by moderate/severe atopic dermatitis (AD), and to investigate the clinical, demographic and
Externí odkaz:
https://doaj.org/article/b53505b790e34e229d8174bf1e7755f4
Publikováno v:
Acta Dermato-Venereologica, Vol 103 (2023)
Several non-randomized clinical trials and retrospective studies have demonstrated encouraging efficacy and well-tolerated safety of tofacitinib in the treatment of alopecia areata. However, there are scarce data on a large cohort of patients with al
Externí odkaz:
https://doaj.org/article/d5e96776e1604dc492c41d811d0c852c
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 15, Pp 2245-2252 (2022)
Ying Li1,2 *, Jia-Jing Lu1,2 *, Xiao-Yuan Zhong1,2 *, Ying-Yuan Yu1,2 *, Ning Yu,1,2 Yu Wang,1,2 Xue-Mei Yi,1,2 Yang-Feng Ding,1,2 Yu-Ling Shi1,2 1Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of
Externí odkaz:
https://doaj.org/article/907528afcfd94acda818af4454b0cc9a